Streetbeat News

Products Services

RDWR

Redwire has started construction on a new 30,000 square foot microgravity payload development and space operations facility at the Novaparke Innovation & Technology Campus in Floyd County, Indiana.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:35 am

ACB

Aurora, a leading medical cannabis company, has launched innovative resin cartridges in Australia in partnership with MedReleaf Australia. This expansion aims to offer greater choice for patients.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:34 am

AVGR

Avinger announced a strategic shift to increase focus on its Coronary Artery Disease program while reducing operating costs in its Peripheral Artery Disease business.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:33 am

OPTT

Ocean Power Technologies (OPTT) has been awarded a contract for a WAM-V for immediate delivery to an offshore construction contractor.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:32 am

GP

GreenPower has introduced the EV Star REEFER X, an all-electric refrigerated transport vehicle with customizable design and increased payload capacity, aimed at revolutionizing refrigerated transport.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:31 am

RKLB

Rocket Lab USA, Inc. (NASDAQ:RKLB) shares are trading higher in the premarket session after successfully completing two Electron launches for NASA’s PREFIRE mission within eleven days. The mission aims to gather climate change data from Earth's polar regions. This marks Rocket Lab's 49th Electron launch and the seventh mission of 2024.

Portfolio Pulse from Nabaparna Bhattacharya

June 05, 2024 | 11:28 am

EPRX

Eupraxia Pharmaceuticals will present results from its Phase 2 study of EP-104IAR for treating osteoarthritis of the knee at the European Rheumatology Congress 2024.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:28 am

CANF

Can-Fite Biopharma announced that its Phase 3 study for Namodenoson, a treatment for advanced liver cancer, is now recruiting at 31 medical centers. Namodenoson has received Orphan Drug status from both the FDA and the European Medicines Agency, as well as FDA Fast Track status. Additionally, a compassionate use program is ongoing in Israel and Romania.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:18 am

ACN

Accenture has entered a three-year partnership with Major League Cricket champions MI New York, becoming its principal partner. The partnership will feature the Accenture logo on MI New York's match and training jerseys and will leverage Accenture's digital services and consulting expertise to enhance team performance through innovative solutions and data-driven strategies.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:15 am

ESTA

The FDA's Center for Devices and Radiological Health has completed its review of Establishment Labs' premarket approval application for Motiva Implants. The application is deemed approvable pending an acceptable FDA inspection of the manufacturing facilities, which has been rescheduled to occur within the next thirty days.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:13 am